S-IGF-II of women in the acute phase of stroke was 10.7 % higher (p < 0.001, Figure 1B) and 11.6% higher 3 months after stroke (p < 0.001), and 7.7 % higher among the controls (p < 0.001). Here, IGF2 is linked to stroke disorder.